According to Ironwood Pharmaceuticals 's latest financial reports the company's current earnings are S$0.37 Billion. In 2023 the company made an earning of -S$1.27 Billion a decrease over its 2022 earnings that were of S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | S$94.63 M | -107.46% |
2023 | -S$1.27 Billion | -475.59% |
2022 | S$0.33 B | 25.8% |
2021 | S$0.26 B | 84.32% |
2020 | S$0.14 B | 84.69% |
2019 | S$78.81 M | -125.13% |
2018 | -S$0.32 Billion | 100.62% |
2017 | -S$0.16 Billion | 43.12% |
2016 | -S$0.11 Billion | -42.73% |
2015 | -S$0.2 Billion | -24.76% |
2014 | -S$0.26 Billion | -30.49% |
2013 | -S$0.37 Billion | 275.65% |
2012 | -S$97.12 Million | 11.56% |
2011 | -S$87.05 Million | 9.38% |
2010 | -S$79.59 Million | -15.21% |
2009 | -S$93.87 Million |